The Jon Block Group serves many of the world’s top medical device firms, providing senior-level management with strategic advisory services, focusing on clinical trial design, development, interpretation, and presentation. The Group specializes in assisting clients disseminate their clinical results through the peer-reviewed journal publication process with the primary mission to expedite regulatory clearance, clinical acceptance and reimbursement approval of emerging and cutting-edge technologies.
The re-branding affirms The Jon Block Group’s commitment to delivering superior pioneering methodologies and deep expertise necessary for life sciences firms to accelerate, and reach, their product development and commercialization goals.
The new visual representation of the brand will appear in the company’s advertising and documentation, and on its products and packaging. A newly re-branded and dynamic Jon Block Group website has been launched, featuring improved functionality and additional tools, including a life science subject matter expertise interactive forum.
About the rebranding campaign, company President and founder Jon Block remarked: “I am absolutely delighted with the unprecedented growth we have enjoyed over the past 2 years due, in large part, to our stepped up business development efforts across several disciplines. Additionally, our positive name recognition, most notably in orthopedics and musculoskeletal medicine, is the result of over 20 years of exemplary service to the industry. This year alone we have accomplished a record setting 22 accepted peer reviewed publications for our clients. We have added some superior talent to our team of highly-dedicated and passionate clinical trialists, allowing us to branch out into sports medicine, plastic and reconstructive surgery, as well as metabolic and cardiopulmonary disorders. Our rebranding effort directly reflects a significant expansion of our talent and depth of expertise.”
The company’s musculoskeletal divison has a certain passion for promising orthopedic medical device technologies, including treatments for sports-related injuries. That, coupled with priding itself in being a progressive corporate citizen, The Jon Block Group will dedicate much of its specialized expertise in orthopedic medical devices, including treatments for sports-related injuries, to a robust sports marketing sponsorship effort.
They are proud to be a principal sponsor of several elite junior motorcycle road racers and tennis athletes. The firm hopes to bolster the level of interest in these sports with other biomedical firms in an effort to expose unique opportunities for global corporate brand building, marketing and revenue optimization.
To learn more about the group, please visit www.JonBlockGroup.com.